Our data showed that TriC10 intake, administration of TriC10 and C10:0, and C10:0 supplementation exerted inhibitory effects on HFD-induced obesity and improved glucose homeostasis by GPR84-mediated GLP-1 secretion in in vivo and in vitro studies. The gene discussed is GCG; the disease is obesity disorder.